Second-Draw PPP Loans Now Available
The SBA reopens the Paycheck Protection Program, providing valuable support to eligible private practice members in the form of a second fully forgivable PPP loan.
View ArticleASPS Executive Committee Approves 2021 Policy Priorities
The Society's 2021 policy priorities – shaped by ASPS member surveys – reflect plastic surgeons' and their patients' advocacy preferences at federal, state levels.
View ArticleState Focus on Gender Affirmation Intensifies
A growing trend introduces serious professional, financial, or criminal penalties for the provision of gender affirming therapies.
View ArticleASPS Responds to a Wave of Scope of Practice Expansion Bills
As efforts to expand scope of practice increase, ASPS opposes legislation with significant implications for the specialty and patient care
View ArticleRegister Today: 2021 ASPS Virtual Advocacy Summit
Join your plastic surgery colleagues at the 2021 ASPS Virtual Advocacy Summit on May 19-26, 2021, to advance the specialty's advocacy agenda in Washington, DC.
View ArticleAttacks on MOC Reemerge
Some states pick up the recent trend of anti-Maintenance of Certification (MOC) legislation.
View ArticleCoding Workshop Breaks Records Amid Major Changes
The accessibility of virtual programming combines with major changes to the CPT codes to produce record attendance at the ASPS Coding Workshop.
View ArticleASPS Maintains Support for ELSA in 117th Congress
As the longtime ASPS federal priority is reintroduced in Congress, the Society works to drive support.
View ArticleThe Ongoing Fight to Stop Medicare Physician Cuts
Recently the Society found itself in a familiar fight against harmful cuts. However, the source of the reductions was unexcepted – the $1.9 trillion American Rescue Plan.
View ArticleFDA Highlights Importance of Physician Training in Dermal Filler Injections
On March 23, the FDA convened its General and Plastic Surgery Devices Advisory Panel to discuss and make recommendations regarding the benefits and risks of dermal fillers.
View ArticleFDA Takes New Steps on ADMs, Promises More
The FDA's recent safety communication about the use of ADM products in implant-based breast reconstruction is the most recent statement from the agency on the issue.
View ArticleASPS Challenges Big Tech Censorship of Gender Affirming Care
Upon discovering a troubling trend of Facebook and Instagram censoring advertisements related to gender-affirming care, ASPS pushed back.
View ArticleASPS Continues to Advocate for Congenital Anomaly Coverage
As ASPS continues its advocacy for increased congenital anomaly coverage at the federal level, similar legislation at the state level has emerged.
View ArticleWave of Bills Seeks to Expand Optometrists' Scope
The 2021 legislative season has seen a wave of legislation that would grant optometrists the ability to perform surgical procedures squarely within the practice of medicine.
View Article2021 Advocacy Summit Makes Major Strides in New Format
The annual ASPS Advocacy Summit was held virtually for the first time this year, allowing physicians the flexibility to participate in a week of action from home.
View Article
